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1. BACKGROUND {#mgg3649-sec-0005}
=============

Wilson\'s disease (WD, *OMIM\#277900*) is an autosomal recessive genetic disease caused by mutations in *ATP7B* (HGNC: 870, VERSION NG_008806.1). *ATP7B* is located on 13q14.3 and contains 20 introns and 21 exons, for a total genomic length of 80 kb (Tanzi et al., [1993](#mgg3649-bib-0009){ref-type="ref"}). *ATP7B* encodes copper‐transporting P‐type ATPase, which is a group of transmembrane copper transport proteins (Petrukhin et al., [1993](#mgg3649-bib-0006){ref-type="ref"}). This protein is composed of 1,465 amino acids that contain a phosphatase domain (A‐domain), a phosphorylation domain (P‐domain), a nucleotide‐binding domain (N‐domain), and eight transmembrane ion channels (M‐domain) (Cater, Fontaine, & Mercer, [2007](#mgg3649-bib-0002){ref-type="ref"}).

Mutation of the *ATP7B* gene is closely linked to the impairment of copper excretion, leading to abnormal deposition of copper in the target organs (Dong & Wu, [2012](#mgg3649-bib-0003){ref-type="ref"}). Variants in the *ATP7B* gene have been reported in almost all exons. More than 700 variants in *ATP7B* have been identified, of which single‐nucleotide missense and nonsense mutations is the most common, followed by insertions/deletions and splice site mutations. Most patients are compound heterozygotes, carrying different mutations on each copy of the chromosome. Due to the diverse clinical manifestations of WD, it can sometimes be difficult to diagnose.

We conducted a molecular analysis of 14 probands and 12 family members and identified six novel variants in the ATP7B gene.

2. PATIENTS AND METHODS {#mgg3649-sec-0006}
=======================

Fourteen probands (three males and 11 females, age from 4 to 43 years old), who presented with hepatic symptoms and decreased ceruloplasmin (\<200 mg/L, normal 200--400 mg/L), were diagnosed with WD from 2012 to 2015 in the YouAn Hospital of Capital Medical University. All probands had at least four points according to the WD scoring system (European Association for the Study of the Liver, [2012](#mgg3649-bib-0004){ref-type="ref"}). Additionally, 11 parents and one sibling of the 14 probands were recruited for the study. They were of the Han ethnicity from North China. Written informed consent was obtained from the participants or their guardians before the genetic investigation was conducted. The Ethics Committee of the Beijing YouAn Hospital of Capital Medical University approved the present work. This study protocol conformed to the ethical guidelines of the Declaration of Helsinki.

The *ATP7B* gene was analyzed by direct sequencing using genomic DNA extracted from leukocytes in peripheral blood (QIAGEN, Germany). The Primers used for PCR assay were showed in Table [1](#mgg3649-tbl-0001){ref-type="table"}. The amplified products were detected by agarose gel electrophoresis and sequenced using an ABI3730 DNA Analyzer (Applied Biosystems, USA). The pathogenicity of the genetic variants was ascertained using the WD allelic variant database (<http://www.wilsondisease.med.ualberta.ca/database.asp>).

###### 

Primers used for PCR assay of *ATP7B* gene exons and promoters

  Primer        Sequences                       Fragment size (BP)
  ------------- ------------------------------- --------------------
  *ATP7B‐*1F    AGCCCTGGGAGCTGAGTCT             781
  *ATP7B‐*1R    AAACATCAGTTGACGGCACA             
  *ATP7B‐*2AF   TCATTTTGTAGATGCTGCCT            829
  *ATP7B‐*2AR   AAGGTCTCTTTGGGTTAGTG             
  *ATP7B‐*2BF   TCAGGGACCATGTAAATGAC            836
  *ATP7B‐*2BR   CAAGGAAAGTTTGCAGGATT             
  *ATP7B‐*3F    GATGGCTGAGGGACAAGGTA            583
  *ATP7B‐*3R    CACAATGCCAGTTATACAAGGA           
  *ATP7B‐*4F    TGTTCTAGAGGATTCTGGGAAGA         394
  *ATP7B‐*4R    CCCAACAACAACAAACCAGA             
  *ATP7B‐*5F    AGGAGGGAAAGGCTCTTGG             396
  *ATP7B‐*5R    TCCATGGGAAAAGTTGAAGAA            
  *ATP7B‐*6F    AGCTGTCTTCCCAGAAGTGC            400
  *ATP7B‐*6R    GCAGCTAATCCAGGAGGAAG             
  *ATP7B‐*7F    TGTAATCCAGGTGACAAGCAG           277
  *ATP7B‐*7R    CACAGCATGGAAGGGAGAG              
  *ATP7B‐*8F    CTACTTGCTGGCAGCCTTCACTG         308
  *ATP7B‐*8R    GGAGCAGCTCTTTTCTGAACCTG          
  *ATP7B‐*9F    CCTGCAGAGCCTTTTATCGT            344
  *ATP7B‐*9R    TCTCTGCCCACACTCACAAG             
  *ATP7B‐*10F   TCAGCAGCTGCACGATAAAT            398
  *ATP7B‐*10R   TCCTAGACGTAGGAAAGAGACAA          
  *ATP7B‐*11F   GGGCTGAGCAAGTGACAGTTG           272
  *ATP7B‐*11R   TGT CTG ATTT CCC AGAA CTCT       
  *ATP7B‐*12F   TCATAGGTTGTAATTTCCCATG          245
  *ATP7B‐*12R   CAGG ATCAA TGT CAG TAGA TTAT     
  *ATP7B‐*13F   GAACCCAAGTTCGTCACGTT            485
  *ATP7B‐*13R   GACTGGTGGCTACTCTGTTGC            
  *ATP7B‐*14F   AGTTCTGCCTCAGGAGTGTGAC          338
  *ATP7B‐*14R   CAG CTA GGAG AGA A GG ACA TGG    
  *ATP7B‐*15F   CTTTCACTTCACCCCTCT              254
  *ATP7B‐*15R   CAGCTGCAGAGACAAAAGC              
  *ATP7B‐*16F   GTTCACAGTGAAATTGGACC            242
  *ATP7B‐*16R   ACTGTATTT CTG AGAGAG CG          
  *ATP7B‐*17F   TTTTGTGTACATCCGTAAATGC          399
  *ATP7B‐*17R   GGGCCAACTGGTGCTTACT              
  *ATP7B‐*18F   GTAACTTGAGGTTTCTGCTG            368
  *ATP7B‐*18R   AGCAAATCATTCTGATGGAG             
  *ATP7B‐*19F   GACATGGGTGTGGCCATT              374
  *ATP7B‐*19R   CCTCTAGCCAGCCAGTGAGT             
  *ATP7B‐*20F   CTGTGGGCAAGATCCATTG             380
  *ATP7B‐*20R   TGCCACTGCAGCATTTGT               
  *ATP7B‐*21F   TCCTTTTCCTTGGAAACTCTTG          500
  *ATP7B‐*21R   CTAGCTCAGCCCATCCTGCT             

F: forward, R: reversed, BP: base pairs.
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3. RESULTS {#mgg3649-sec-0007}
==========

By direct sequence analysis of the entire *ATP7B* gene coding and promoter regions, we identified 29 different variants. (27 substitutions, one duplication, one deletion). Of these 29 variants, six were novel variants and 23 reported variants previously (Table [2](#mgg3649-tbl-0002){ref-type="table"}). The variants occurred most frequently in exons 8, 13, 16, and 18. No variants were found in exon 1, 4, 7, 9, and 19. Among the 23 reported mutations, we found nine nondiseased‐variants (NDV), 11 diseased‐variants (DV), one silent‐variant, and two uncertain function variants (DV or NDV) according the WD allelic variant database (<http://www.wilsondisease.med.ualberta.ca/database.asp>). The variants were classified into benign, likely benign, uncertain significance, likely pathogenic and pathogenic based on ACMG/AMP 2015 guideline (Richards et al., [2015](#mgg3649-bib-0007){ref-type="ref"}) (<http://wintervar.wglab.org/>). The most frequent variants were c.2855A\>G, c.3419C\>T, and c.3903+6T\>C, which were NDV. For 11 DVs, the most frequent was c.2333G\>T, followed by c.2304dupC, c.2621C\>T, c.588C\>A, c.1708‐5T\>G, c.2827G\>A, c.2975C\>T, c.3053C\>T, c.3646G\>A, c.A3809A\>G, and c.4114C\>T. 1 silent‐variant is c.2310C\>G. 2 controversial variants (DV or NDV) are c.3316G\>A and c.3443T\>C.

###### 

The 29 variants identified in the 14 probands with WD

           Variant name (nucleotide)   Nucleotide sequence   Variant type   Amino acid chang     Result of change   Area of protein     Reported status   Classification      No. of alleles   Allele frequency (%)
  -------- --------------------------- --------------------- -------------- -------------------- ------------------ ------------------- ----------------- ------------------- ---------------- ----------------------
  5′       c.*‐*128C\>A                                      Substitution                        Unknown            5UTR                NDV                                   4                14.3
  5′       c.*‐*75A\>C                                       Substitution                        Unknown            5UTR                NDV                                   5                17.9
  Exon2    c.588C\>A                   GAC‐GAA               Substitution   p.Asp196Glu          Missense           Cu2                 DV                Pathogenic          1                3.6
  Exon2    c.1216T\>G                  TCT‐GCT               Substitution   p.Ser406Ala          Missense           Cu4                 NDV               Pathogenic          4                14.3
  Exon3    c.1366G\>C                  GTG‐CTG               Substitution   p.Val456Leu          Missense           bet Cu4/Cu5         NDV               Uncertain           6                21.4
  Exon5    c.1708*‐*5T\>G                                    Substitution                        Splice             Cu6                 DV                                    1                3.6
  Exon6    c.1875T\>A                  ATT‐ATA               Substitution   p.Ile625Ile          Synonymous         Cu6                 Novel                                 1                3.6
  Exon8    c.2304dupC                  CCCCATG               Duplication    p.Met769Hisfs\*26    Termination        TM4                 DV                Pathogenic          2                7.1
  Exon8    c2306T\>C                   ATG‐ACT               Substitution   p.Met769Thr          Missense           TM4                 Novel             Uncertain           1                3.6
  Exon8    c.2310C\>G                  CTC‐CTG               Substitution   p.Leu770Leu          Synonymous         TM4                 Sil               Likely Benign       7                25
  Exon8    c.2333G\>T                  CGG‐CTG               Substitution   p.Arg778Leu          Missense           TM4                 DV                Likely Pathogenic   6                21.4
  Exon10   c.2495A\>G                  AAG‐AGG               Substitution   p.Lys832Arg          Missense           TM4/Td              NDV               Uncertain           6                21.4
  Exon11   c.2621C\>T                  GCG‐GTG               Substitution   p.Ala874Val          Missense           bet Td/TM5          DV                Pathogenic          2                7.1
  Exon12   c.2827G\>A                  GGT‐AGT               Substitution   p.Gly943Ser          Missense           TM5                 DV                Pathogenic          1                3.6
  Exon12   c.2855A\>G                  AAA‐AGA               Substitution   p.Lys952Arg          Missense           bet M5/TM6          NDV                                   12               42.9
  Exon13   c.2975C\>T                  CCC‐CTC               Substitution   p.Pro992Leu          Missense           bet TM6/Ph          DV                Likely Pathogenic   1                3.6
  Exon13   c.3028A\>G                  AAG‐GAG,              Substitution   p.Lys1010Glu         Missense           bet TM6/Ph          Novel             Pathogenic          1                3.6
  Exon13   c.3053C\>T                  GCG‐GTG               Substitution   p.Ala1018Val         Missense           bet TM6/Ph          DV                Pathogenic          1                3.6
  Exon14   c3243G\>A                   GAG‐GAA               Substitution   p.Gln1081Gln         Synonymous         ATP loop            Novel                                 1                3.6
  Exon15   c.3316G\>A                  GTC‐ATC               Substitution   p.Val1106Ile         Missense           ATP loop            DV or NDV         Pathogenic          2                7.1
  Exon16   c.3419C\>T                  GCC‐GTC               Substitution   p.Val1140Ala         Missense           ATP loop            NDV                                   12               42.9
  Exon16   c.3437_3438delTG            TGC                   Deletion       p.Val1146Ala fs\*6   Frameshift         ATP loop            Novel             Pathogenic          1                3.6
  Exon16   c.3443T\>C                  ATT‐ACT               Substitution   p.Ile1148Thr         Missense           ATP loop            DV or NDV         Pathogenic          1                3.6
  Exon17   c.3646G\>A                  GTG‐ATG               Substitution   p.Val1216Met         Missense           ATP bind            DV                Pathogenic          1                3.6
  Exon18   c.3809A\>G                  AAT‐AGT               Substitution   p.Asn1270Ser         Missense           ATP hinge           DV                Pathogenic          1                3.6
  Exon18   c.3889G\>A                  GTC‐ATC               Substitution   p.Val1297Ile         Missense           bet ATP hinge/TM7   NDV               Pathogenic          1                3.6
  Exon18   c.3903+5A\>G                gaatgtg‐gagcgtg       Substitution                        Splice             bet ATP hinge/TM7   Novel                                 1                3.6
  Exon18   c.3903+6T\>C                gaatgtg‐gagcgtg       Substitution                        Splice             bet ATP hinge/TM7   NDV                                   11               39.3
  Exon20   c.4114C\>T                  CAG‐TAG               Substitution   p.Gln1372Ter         Nonsense           TM8                 DV                Pathogenic          1                3.6

Reported status: variants according WD allelic variant database.

Classification: variants into "Benign", "Likely benign", "Uncertain significance", "Likely pathogenic", and "Pathogenic" based on ACMG/AMP 2015 guideline.

DV: disease variants, NDV: nondisease variants, UTR: untranslated regions, Cu: copper binding domain, TM: transmembrane domain, Ph: phosphorylation loop, bet: between; WD: Wilson\'s disease.
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The six novel variants included two synonymous mutations (c.1875T\>A and c.3243G\>A) and four possible disease variants (DVs) (c.2306T\>C, c.3028A\>G, c.3437_3438 delTG, and c.3903+5G\>A) (Figure [1](#mgg3649-fig-0001){ref-type="fig"}). The disease variants and novel variants from the 14 probands with WD showed in Table [3](#mgg3649-tbl-0003){ref-type="table"}.

![Chromatograms of six novel ATP7B variants. The lower nucleotide symbols in each frame represents the variant, while the upper one represents the normal sequence. The red arrow shows the variation point. (a) c.1875T\>A, (b) c2306T\>C, (c) c.3028A\>G, (d) c3243G\>A, (e) c.3437_3438delTG, (f) c3903+5G\>A and reported c.3903+6T\>C](MGG3-7-e649-g001){#mgg3649-fig-0001}

###### 

The disease variants and novel variants from the 14 probands with WD

  Case   Gender   Age   CER (mg/L)   Genotype                Family                                                             Variant                                              
  ------ -------- ----- ------------ ----------------------- -------- --------------------------------------------------------- --------------------------------------------------- ------------
  1      F        23    26           Compound heterozygote            c.2333G\>T                                                c.2621C\>T                                           
  2      F        6     45           Compound heterozygote            c.1875T\>A[a](#mgg3649-note-0007){ref-type="fn"}          c.2333G\>T                                          c.3443T\>C
  3      F        4     21           Simple heterozygote              c.3809A\>G                                                                                                     
  4      F        8     22           Compound heterozygote   A        c.3437_3438 delTG[a](#mgg3649-note-0007){ref-type="fn"}   c.4114C\>T                                           
  5      M        43    125          Compound heterozygote   B        c.588C\>A                                                 c.2827G\>A                                          c.3316G\>A
  6      F        5     19           Compound heterozygote   C        c.2333G\>T                                                c.3646G\>A                                           
  7      F        30    19           Compound heterozygote            c.3028A\>G[a](#mgg3649-note-0007){ref-type="fn"}          c.3053C\>T                                           
  8      F        23    19           Compound heterozygote            c1708*‐*5T\>G                                             c3243G\>A[a](#mgg3649-note-0007){ref-type="fn"}      
  9      F        7     21           Compound heterozygote   D        c.2304dupC                                                c.2975C\>T                                           
  10     M        7     79           Simple heterozygote     E        c.2306T\>C[a](#mgg3649-note-0007){ref-type="fn"}                                                               
  11     F        7     58           Simple heterozygote     F        c.2304dupC                                                                                                     
  12     F        19    22           Simple homozygote                c.2333G\>T                                                                                                     
  13     M        16    22           Compound heterozygote            c.2621C\>T                                                3,903+5G\>A[a](#mgg3649-note-0007){ref-type="fn"}    
  14     F        9     31           Compound heterozygote   G        c.2333G\>T                                                c.3316G\>A                                          　

Unmarked: reported disease variants.

CER: ceruloplasmin; WD: Wilson\'s disease.

Novel.
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4. DISCUSSION {#mgg3649-sec-0008}
=============

Mutation hotspots in *ATP7B* vary by geographic region, with a higher prevalence of specific variants reported in certain populations. The predominant variants in the Chinese population include c.2333G\>T (p.Arg778Leu), c.2975C\>T (p.Pro992Leu), c.3443T\>C (p.Ile1148Thr), and c.2804C\>T (p.Thr935Met) (Gu et al., [2003](#mgg3649-bib-0005){ref-type="ref"}; Wang et al., [2011](#mgg3649-bib-0010){ref-type="ref"}; Wei et al., [2014](#mgg3649-bib-0011){ref-type="ref"}). In our study, the most frequently observed DVs were c.2333G\>T, c.2304dupC, c.2621C\>T, c.588C\>A, c.1708‐5T\>G, c.2827G\>A, c.2975C\>T, c.3053C\>T, c.3646G\>A, c.A3809A\>G, and c.4114C\>T. The one silent variant was c.2310C\>G. The two uncertain variants (DVs or NDVs) were c.3316G\>A and c.3443T\>C.

In our study, we found six novel variants, of which two were synonymous mutations (c.1875T\>A and c.3243G\>A) and four were possible DVs (c.2306T\>C, c.3028A\>G, c.3437_3438 delTG, and c.3903+5G\>A).

The c.2306T\>C (ATG‐ACT, p.Met769Thr) mutation was newly found. At the same amino acid position, two mutations (c.2305A\>G, ATG‐GTG, p.Met769Val and c.2306T\>G, ATG‐AGG, p.Met769Arg) have been reported as DVs. The novel c.2306T\>C heterozygous mutation was found in a child proband and his father. This mutation affects Cu transport by creating a conservative amino acid change in Tm4. The c.3028A\>G（AAG‐GAG, p.Lys1010Glu）mutation is regarded as a new DV. At the same amino acid position, three DVs have been verified previously (Santhosh et al., [2008](#mgg3649-bib-0008){ref-type="ref"}). It is found a compound heterozygote patient carrying c.3028A\>G mutation and the known pathogenic variant c.3053C\>T. We found a novel variant in exon 16, c.3437_3438 delTG (p.Val1146Ala fs\*6). In a previous study, it was found that the c.3436G\>A (p.Val1146Met) missense mutation at amino acid position 1146 is a DV (Antonietta et al., [2008](#mgg3649-bib-0001){ref-type="ref"}). Generally, frameshift and missense mutations are associated with more severe phenotypes of WD. Furthermore, the compound heterozygote proband with the novel variant (c.3437_3438 delTG) and another DV (c.4114C\>T, p.Gln1372Ter) was diagnosed with WD. This proband\'s father had a novel variant, and the proband\'s mother had another DV (c.4114C\>T, p.Gln1372Ter); both were diagnosed as WD carriers because they were simple heterozygotes. Therefore, the novel variant (c.3437_3438 delTG) is likely to be a DV. A novel variant (c.3903+5G\>A) was found in exon 18. Similarly, the c.3903+6T\>C splice variant is a nondisease variant (NDV) (Gu et al., [2003](#mgg3649-bib-0005){ref-type="ref"}) and the novel c.3903+5G\>A splice variant was speculated to be a NDV. However, in our study, a patient carried the novel variant (c.3903+5G\>A), a DV (c.2621C\>T), and three NDVs (c.2855A\>, c.3419C\>T, and c.3903+6C\>T). The pathological significance of the novel variant (c.3903+5G\>A) requires more study in future.

Summary, genetic testing is a valuable tool to detect WD. The results add data to the spectrum of known mutations in the *ATP7B* gene in Chinese Han population.
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